1. Home

Wegovy woes: Nothing feels as good as big fat skinny profits

 
• By James Halliwell

Wegovy and Ozempic are delivering fat profits from making people skinny. Manufacturer Novo Nordisk expects voluptuous $40bn sales in 2024, up 18% on 2023. But one doctor warns death will follow if the status quo continues...

Semaglutide injection
James Halliwell

Read more by James Halliwell

James Halliwell joined C+D as editor-in-chief in February 2024. A business journalist for the last 15 years, he’s looking forward to developing the bond between C+D and its readers and bringing them more of what they want to read, in the evolving ways they want to read it.

Latest from Opinion

More from Analysis